What Does Insufficient Squamous Cellularity Mean?

Insufficient squamous cellularity means the Pap smear sample did not contain enough cells from the surface of the cervix for a pathologist to confidently evaluate it. In practical terms, it is not a diagnosis and does not mean something is wrong with your cervix. It means the lab could not read the slide well enough to give you a clear result, so the test will need to be repeated. This is the single most common reason a Pap smear comes back labeled “unsatisfactory,” accounting for roughly two-thirds of all unsatisfactory results in one large analysis.¹

What the Lab Is Actually Looking For

When a Pap smear arrives at a laboratory, the pathologist needs to see a minimum number of squamous cells, the flat cells that line the outer surface of the cervix, to make any meaningful assessment. The traditional benchmark has been that these cells should cover at least 10% of the slide. If the sample falls below that threshold, the lab reports it as having insufficient squamous cellularity, which makes the entire Pap result “unsatisfactory.” An unsatisfactory result is essentially a non-result: the lab cannot say whether your cells look normal or abnormal because there simply were not enough of them to judge.

Deciding whether a slide meets that threshold is more subjective than you might expect. In a study where 13 pathologists reviewed the same set of 40 Pap smears, only 15 slides received a unanimous verdict on whether the squamous component was adequate. The level of agreement among reviewers was moderate at best, and it improved somewhat when standardized reference images were introduced alongside updated criteria.² Broader surveys of laboratory practices have confirmed this variability, with significant differences in how labs apply adequacy standards.³ So a slide that one lab calls unsatisfactory might pass at another. This does not mean the standard is meaningless; it means there is a gray zone, and your sample may have fallen right in it.

Why It Happens

The reasons for insufficient cellularity usually fall into two buckets: something about the collection itself went wrong, or something about your body at the time of the test made it harder to get a good sample.

On the collection side, technique matters a great deal. The clinician uses a brush or spatula to sweep cells from the cervix, and the device needs to be rotated enough times, pressed firmly enough, and transferred to the slide or liquid vial quickly enough to preserve the cells.⁴ If the brush does not contact the cervix well, or if the sample dries out before it is fixed on the slide, fewer intact cells make it to the lab. The experience level of the person collecting the sample, the type of sampling device used, and even the staining procedure in the lab can all affect cellularity.⁵

On the body side, several conditions can thin out the cells available to collect. Menopause is the big one. After estrogen levels drop, the vaginal and cervical tissues become thinner and drier, a condition called vulvovaginal atrophy that affects close to half of postmenopausal women.⁶ Thinner tissue simply sheds fewer cells, so even a perfectly performed collection may not yield enough. Older age and cervical erosion have been identified as important predictors of an unsatisfactory result.¹ Blood, heavy mucus, or inflammatory discharge can also obscure the cells that are present, making the slide unreadable even if enough cells were technically collected.⁷ Scheduling a Pap during your period, or during an active vaginal infection, raises the odds of this kind of interference.

Does It Mean You Might Have Cancer?

This is the question behind the question for most people who search this topic, and the short answer is reassuring. An unsatisfactory Pap smear on its own does not indicate a higher likelihood of cervical cancer. Several follow-up studies have tracked women who received unsatisfactory results to see what happened next, and the findings consistently show that the vast majority turn out to be fine.

In one retrospective study that followed 67 women with unsatisfactory Pap results over two years, every single one tested negative for malignancy on repeat testing.⁸ A separate study using liquid-based Pap tests found that unsatisfactory results were not associated with an increased rate of significant precancerous changes compared to women whose Paps were satisfactory.⁹

That said, the picture is not perfectly simple. A large prospective study that repeated testing on over 1,200 women with initially inadequate smears found that about 2.6% had a cervical lesion detected on their repeat test, and less than 1% had a report of cervical atypia.¹⁰ And in a high-risk population, one study found that about 29% of patients with unsatisfactory smears had some kind of follow-up abnormality, though this group was specifically selected because they already had elevated risk factors.¹¹ The takeaway is not that insufficient cellularity hides cancer, but that any time a screening test cannot be read, you lose the reassurance that a normal result would have given you. That is why repeating the test matters.

What HPV Testing Adds

Many Pap smears today are ordered alongside an HPV test, a practice called cotesting. This turns out to be particularly useful when the Pap result comes back unsatisfactory, because the HPV test may still be readable even when the Pap slide is not. If your HPV test comes back negative alongside an unsatisfactory Pap, the chance that you are harboring a significant precancerous lesion is very low. One analysis found that among women with unsatisfactory Paps, a negative HPV cotest had a negative predictive value of about 99.6% for high-grade lesions.¹² In other words, if your HPV test is negative, the odds that you have a serious cervical abnormality being missed are extremely small.

The flip side is that if the HPV test comes back positive alongside an unsatisfactory Pap, the clinician has reason for closer follow-up. In the same analysis, the rate of high-grade lesions jumped to about 5.7% in HPV-positive cases, compared to 0.4% in HPV-negative cases.¹² That does not mean you have cancer, but it does mean the provider will likely want to repeat the Pap promptly or consider colposcopy rather than wait.

What Happens Next

Current guidelines from the American Society for Colposcopy and Cervical Pathology recommend that if your Pap is unsatisfactory and you either did not have an HPV test, the HPV result is unknown, or it came back negative, the test should be repeated as soon as is convenient and no later than four months.¹³ This is not a rushed timeline meant to signal alarm. Four months gives your cervix time to recover from the collection process and any inflammation, while still keeping the follow-up close enough that you are not left in limbo for a year.

If you had a positive HPV result with the unsatisfactory Pap, your provider will follow HPV-specific management pathways, which can range from an earlier repeat to direct referral for colposcopy depending on additional details like the specific HPV type and your screening history. The key point is that an unsatisfactory Pap does not get filed away and ignored. It always triggers some kind of follow-up.

How to Reduce the Odds on Your Repeat Test

Since the most common cause of insufficient cellularity is simply not getting enough cells onto the slide, there are practical steps that can improve the yield on your next visit.

Timing: Avoid scheduling the test during your period or within a couple of days of it. Blood is one of the main things that obscures cells on a slide.
Vaginal products: Skip vaginal creams, lubricants, douches, and spermicides for at least 48 hours before the appointment. These can coat the cervix and interfere with cell pickup.
Intercourse: Abstaining for a day or two beforehand reduces the presence of seminal fluid and other debris that can make the sample harder to read.
Infection treatment: If you had an active infection at the time of the first test, get it treated before the repeat. Inflammatory cells can overwhelm the squamous cells the lab needs to see.

For postmenopausal women whose atrophic tissue was the likely culprit, a short course of vaginal estrogen before the repeat Pap can make a substantial difference. A randomized trial found that using vaginal estrogen for five nights before the test dramatically reduced the odds of getting an atrophic smear result, while a single dose had no meaningful effect.¹⁴ The estrogen temporarily plumps up the vaginal and cervical tissue, allowing more cells to shed and be collected. Studies of other moisturizing agents like hyaluronic acid vaginal cream have also shown improvements in cellular maturation, though estrogen remains the better-studied option.¹⁵

The Collection Device Makes a Difference

The tool your clinician uses to collect the sample is not something you typically have a say in, but it does affect the chances of getting an adequate specimen. A systematic review published in The Lancet found that the traditional Ayre’s spatula, which has been used for decades, is less effective at collecting endocervical cells compared to extended-tip spatulas and brush-type devices.¹⁶ A more recent comparative study found that a conical brush device yielded adequate smears in about 92% of cases compared to roughly 79% with the Ayre’s spatula.¹⁷

Liquid-based cytology, where the brush is rinsed into a vial of preservative fluid rather than smeared directly onto a glass slide, also tends to produce fewer unsatisfactory results. In one head-to-head comparison, about 5% of conventional Pap smears were judged poor quality, compared to only about 1.4% of liquid-based preparations from the same patient group.¹⁸ The liquid method reduces the chance of air-drying damage and clumping that can make conventional slides unreadable. If you have had repeated unsatisfactory results with conventional Paps, it is worth asking whether liquid-based cytology is available at your clinic.

The Anxiety Is Real and Normal

Getting an “unsatisfactory” result from a cancer screening test is psychologically confusing in a way that the medical system does not always acknowledge. Research has shown that women who receive an inadequate smear result experience significantly higher anxiety than women who get a normal result, and their worry levels are comparable to those of women who receive an abnormal result.¹⁹ Women with inadequate results also perceived themselves as being at higher risk of cervical cancer and felt less satisfied with the information they received about what the result meant.

This is understandable. The word “unsatisfactory” sounds ominous, and most result letters do a poor job of explaining that it is a comment about the sample, not about your health. If you are feeling anxious after getting this result, recognize that your reaction is shared by most people in the same situation and that the data on what these results actually predict is overwhelmingly reassuring. The discomfort is in the uncertainty, not in any elevated danger.

When Repeat Unsatisfactory Results Keep Happening

Most people who get one unsatisfactory result will get a normal, readable result the second time. In the large prospective cohort study mentioned earlier, about 11% of women who had an initially inadequate smear had a second inadequate smear on repeat testing, while about 86% came back with normal results.¹⁰ But for the minority who keep getting unsatisfactory results, the situation can feel frustrating.

Persistent unsatisfactory Paps tend to cluster in specific groups: postmenopausal women with significant atrophy, women who have had radiation therapy to the pelvis, and women with cervical abnormalities that make the sampling zone difficult to access.⁷ In these situations, clinicians may try vaginal estrogen therapy before the next collection, switch to a different collection device or cytology method, or in some cases move directly to colposcopy so the cervix can be examined visually rather than relying on a slide that keeps coming up short. The ASCCP guidelines allow for clinical judgment when repeated unsatisfactory results prevent adequate screening, and your provider can tailor the approach based on your risk factors and history.

What the Test Cannot Tell You Even When It Works

Even when a Pap smear has plenty of squamous cells and comes back “satisfactory,” the test has its own blind spots. One worth knowing about involves endocervical cells, the glandular cells from the inner canal of the cervix. A satisfactory Pap slide might not include these cells, and their absence is noted on the lab report separately from squamous cellularity. In one comparison study, endocervical cells were present in only 49% of conventional Pap smears, compared to 60% of liquid-based preparations.¹⁸ When endocervical cells are absent, the lab may still call the sample satisfactory, but with the caveat that the transformation zone, the area where most cervical cancers originate, may not have been fully sampled. This is a separate issue from insufficient squamous cellularity, but it often appears on the same result letter and can add to the confusion.

Automated rescreening systems have been developed to flag slides that might have been under-read by a human reviewer, including slides with borderline cellularity. One such system was able to detect slides with an inadequate squamous cell component with about 82% sensitivity.²⁰ These tools serve as a quality check, but they also illustrate that determining adequacy is not always clear-cut even for machines. The cellularity threshold is a practical line drawn in a continuous spectrum, and reasonable observers, human or automated, will sometimes disagree about which side of that line a given slide falls on.

1
PubMed Central. Predictors of Unsatisfactory Conventional Pap Smears
2
PubMed. Interobserver variability in assessing adequacy of the squamous component in conventional cervicovaginal smears
3
PubMed. Specimen adequacy evaluation in gynecologic cytopathology: current laboratory practice in the College of American Pathologists Interlaboratory Comparison Program and tentative guidelines for future practice
4
Scientific Reports. Clinical characteristics and a 2-year follow-up of unsatisfactory conventional Pap smears: a retrospective case-control study – Section: Materials and methods
5
PubMed Central. Institutional Study on Unsatisfactory Pap Smears: Causes and Clinical Impact – Section: Discussion and Conclusion
6
PubMed Central. Vulvovaginal atrophy – Section: Abstract
7
European Journal of Obstetrics & Gynecology and Reproductive Biology. Clinical determinants and smear characteristics of unsatisfactory conventional cervicovaginal smears – Section: Abstract
8
Scientific Reports. Clinical characteristics and a 2-year follow-up of unsatisfactory conventional Pap smears: a retrospective case-control study – Section: Results
9
PubMed Central. Follow-up and Clinical Significance of Unsatisfactory Liquid-based Pap Tests – Section: Results
10
SciELO – Sao Paulo Medical Journal. Follow-up of women with inadequate Pap smears: a prospective cohort study – Section: RESULTS
11
Journal of the American Society of Cytopathology. Common causes for unsatisfactory Pap tests in a high-risk population: insights into a yet unresolved problem in gynecologic cytology – Section: Results
12
PubMed. HPV Cotesting of Unsatisfactory Papanicolaou Tests: Implications for Follow-up Intervals – Section: RESULTS
13
PubMed Central. 2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023 – Section: 2019 GUIDELINE SUBSTANTIVE RECOMMENDATIONS CHANGES AND UPDATES
14
PubMed. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears – Section: RESULTS
15
PubMed Central. Comparison of the Hyaluronic Acid Vaginal Cream and Conjugated Estrogen Used in Treatment of Vaginal Atrophy of Menopause Women: A Randomized Controlled Clinical Trial – Section: Results
16
The Lancet. Does design of cervical-smear collection devices affect adequacy and yield of cytological abnormality? A systematic review – Section: Summary
17
PubMed Central. Comparative study on the adequacy of cervical smears using wooden Ayre’s spatula, VS Papcone sampling device – Section: Results
18
PubMed Central. A Comparison of Conventional Pap Smear and Liquid-Based Cytology for Cervical Cancer Screening – Section: Results
19
PubMed Central. Psychological costs of inadequate cervical smear test results – Section: Abstract
20
Diagnostic Cytopathology. Effectiveness of automated cervical cytology rescreening using the AutoPap 300 QC System – Section: Abstract